home / stock / clrb / clrb news

CLRB News and Press, Cellectar Biosciences Inc. From 07/12/21

Stock Information
Company Name: Cellectar Biosciences Inc.
Stock Symbol: CLRB
Market: NASDAQ
Website: cellectar.com
Menu
CLRB CLRB Quote CLRB Short CLRB News CLRB Articles CLRB Message Board
Get CLRB Alerts

News, Short Squeeze, Breakout and More Instantly...
CLRB - Cellectar Announces a Co-Development and Commercialization Collaboration with LegoChemBio for New Small Molecule Phospholipid Drug Conjugates (PDCs)

FLORHAM PARK, N.J., July 12, 2021 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery and development of drugs for the treatment of cancer, today announced that it has entered into a development and co...
CLRB - Cellectar to Participate in the Ladenburg Thalmann 2021 Virtual Healthcare Conference

FLORHAM PARK, N.J., July 08, 2021 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery and development of drugs for the treatment of cancer, today announced that James Caruso, president and CEO, will pr...

CLRB - Cellectar Announces the Election of Dr. Asher Alban Chanan-Khan to Its Board of Directors

FLORHAM PARK, N.J., June 24, 2021 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery and development of drugs for the treatment of cancer, today announced that Dr. Asher Alban Chanan-Khan has been ele...

CLRB - Cellectar shares fall after mid-stage CLR 131 trial data

Cellectar Biosciences shares slide ([[CLRB]] -13.2%) after posting data from its mid-stage study of CLR 131 in patients with Waldenstrom’s macroglobulinemia ((WM)), a rare and incurable disease, at the American Society of Clinical Oncology ((ASCO)) Annual meeti...
CLRB - SENS, ADMP, LPTH and NGL among midday movers

Gainers: SemiLEDs (LEDS) +66%.Senseonics (SENS) +49%.Windtree Therapeutics (WINT) +38%.MoSys (MOSY) +34%.Ra Medical Systems (RMED) +29%.LightPath Technologies (LPTH) +27%.American Superconductor (AMSC) +26%.Smart Sand (SND) +25%.The9 (NCTY) +24%.Vinco Ventures (BBIG) +22%....

CLRB - Cellectar shares fall after mid-stage CLR 131 trial data fails to impress

Cellectar Biosciences shares slide ([[CLRB]] -13.2%) after posting data from its mid-stage study of CLR 131 in patients with Waldenstrom’s macroglobulinemia ((WM)), a rare and incurable disease, at the American Society of Clinical Oncology ((ASCO)) Annual meeti...

CLRB - Windtree Therapeutics, Senseonics leads healthcare gainers; Harpoon Therapeutics, Purple Biotech among major losers

Gainers: Windtree Therapeutics (WINT) +57%, Senseonics (SENS) +38%, Ra Medical Systems (RMED) +22%, Cullinan Oncology (CGEM) +20%, Progenity (PROG) +10%.Losers: Harpoon Therapeutics (HARP) -25%, Purple Biotech (PPBT) -19%, Adamis Pha...
CLRB - Cellectar Presents Data in Waldenstrom's Macroglobulinemia in Poster at the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting

Mean treatment free remission 1.1 years and remains ongoing Progression free survival for MYD88 wild type and high-risk patients 18 months and ongoing FLORHAM PARK, N.J., June 04, 2021 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical...

CLRB - Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Good morning! Let’s get ready for another busy day of trading with a look at the biggest pre-market stock movers for Wednesday. Source: ventdusud / Shutterstock.com But before that. It’s important to m...

CLRB - Cellectar Announces Poster Presentation of CLR 131 Data in Waldenstrom's Macroglobulinemia at the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting

FLORHAM PARK, N.J., May 20, 2021 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery and development of drugs for the treatment of cancer, today announced a poster presentation at the American Society ...
Previous 10 Next 10